Photothermal/photodynamic
therapy (PTT/PDT) and synergistic therapeutic
strategies are often sought after, owing to their low side effects
and minimal invasiveness compared to chemotherapy and surgical treatments.
However, in spite of the development of the most PTT/PDT materials
with good tumor-inhibitory effect, there are some disadvantages of
photosensitizers and photothermal agents, such as low stability and
low photonic efficiency, which greatly limit their further application.
Therefore, in this study, a novel bismuth-based hetero-core–shell
semiconductor nanomaterial BiNS–Fe@Fe with good photonic stability
and synergistic theranostic functions was designed. On the one hand,
BiNS–Fe@Fe with a high atomic number exhibits good X-ray absorption,
enhanced magnetic resonance (MR) T2-weighted imaging, and
strong photoacoustic imaging (PAI) signals. In addition, the hetero-core–shell
provides a strong barrier to decline the recombination of electron–hole
pairs, inducing the generation of a large amount of reactive oxygen
species (ROS) when irradiated with visible–NIR light. Meanwhile,
a Fenton reaction can further increase ROS generation in the tumor
microenvironment. Furthermore, an outstanding chemodynamic therapeutic
potential was determined for this material. In particular, a high
photothermal conversion efficiency (η = 37.9%) is of significance
and could be achieved by manipulating surface decoration with Fe,
which results in tumor ablation. In summary, BiNS–Fe@Fe could
achieve remarkable utilization of ROS, high photothermal conversion
law, and good chemodynamic activity, which highlight the multimodal
theranostic potential strategies of tumors, providing a potential
viewpoint for theranostic applications of tumors.